Platform
Features
Pricing
0 followers
Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.
Industries
Headquarters
Employees
Links
Jeffrey Wager
3 members
Ro
38 followers
Immunome
2 followers
Amgen
208 followers
Frontier Health
13 followers
Mochi
1 follower
Medidata Solutions
26 followers
Jovian
FS
17 followers
Mountainside
Cytokinetics
11 followers
Artisanal Talent Group
8 followers
Explore companies